Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Seeing Black Gives Regeneron a 9% Pop
Motley Fool
Saturday, April 28, 2012 - 11:35am
tags:
Regeneron, Eylea, macular degeneration
What Chance do these Blockbusters Really Have of Working?
Motley Fool
Saturday, April 28, 2012 - 11:33am
tags:
drug approvals
FDA Throws Pozen A Curveball
Seeking Alpha
Friday, April 27, 2012 - 6:02pm
tags:
FDA, Pozen, PA-325/40
Jazz Pharma to buy EUSA for up to $700M
Yahoo/AP
Friday, April 27, 2012 - 11:55am
tags:
Jazz Pharmaceuticals, EUSA, M&A
ImmunoGen fiscal 3Q loss widens as expenses rise
Yahoo/AP
Friday, April 27, 2012 - 11:43am
tags:
earnings, Immunogen
Arena Pharma's Data Points to Blockbuster Weight-Loss Drug Approval
Motley Fool
Friday, April 27, 2012 - 11:30am
tags:
Arena Pharmaceuticals, obesity, lorcaserin
Massachusetts House Votes To Repeal Gift Ban
Pharmalot
Friday, April 27, 2012 - 11:26am
tags:
physician gifts, Massachusetts
Novo Nordisk plans 15 percent expansion of U.S. work force in 2012
Yahoo
Friday, April 27, 2012 - 11:10am
tags:
Novo Nordisk, hirings
Higher Costs Hurt Gilead
Yahoo/Zacks
Friday, April 27, 2012 - 11:09am
tags:
Gilead, earnings
Will the FDA Approve VIVUS' Avanafil?
Motley Fool
Friday, April 27, 2012 - 11:08am
tags:
FDA, Vivus, Avanafil, erectile dysfunction
Pfizer Near A 4-Year High Headed Into Q1 Earnings
Seeking Alpha
Friday, April 27, 2012 - 11:07am
tags:
Pfizer, earnings
FDA rejects Amgen's application for Xgeva
Reuters
Friday, April 27, 2012 - 10:31am
tags:
FDA, Amgen, prostate cancer, Xgeva
Sanofi First-Quarter Net Climbs 13% on Genzyme, Lantus
Bloomberg
Friday, April 27, 2012 - 10:30am
tags:
earnings, Sanofi
Novo Nordisk saw strong Q1 insulin competition -CFO
Reuters
Friday, April 27, 2012 - 10:19am
tags:
earnings, insulin, Novo Nordisk
GlaxoSmithKline and Genmab A/S submit NDA to MHLW for Arzerra
Yahoo/Fly on the Wall
Friday, April 27, 2012 - 10:18am
tags:
Genmab, GSK, Arzerra, Japan, chronic lymphocytic leukemia
Bullish Sign: Zalicus Shareholders Receive Good News
Seeking Alpha
Friday, April 27, 2012 - 10:16am
tags:
Zalicus, Novartis
The Drama Continues At Amylin Pharmaceuticals: Takeover Still Likely
Seeking Alpha
Friday, April 27, 2012 - 10:16am
tags:
Amylin, M&A, Bristol-Myers Squibb, Sanofi, Eli Lilly
Merck Profit Tops Analyst Estimates on Diabetes Drugs
Bloomberg
Friday, April 27, 2012 - 10:15am
tags:
earnings, Merck
Spectrum profit soars on higher sales of colon drug
Reuters
Thursday, April 26, 2012 - 11:16am
tags:
Spectrum Pharmaceuticals, earnings
Biogen Idec, Inc. First Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Thursday, April 26, 2012 - 11:16am
tags:
earnings, Biogen Idec

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.